Blocking ERK signaling in mutant BRAF melanoma cells with RAF or MEK inhibitors induces FOXD3 expression at the transcriptional level11; however, the underlining mechanism of this regulation is unknown. The gene discussed is MAPK1; the disease is melanoma.